DE602006008752D1 - Neue regulatorische elemente enthaltende vektoren - Google Patents

Neue regulatorische elemente enthaltende vektoren

Info

Publication number
DE602006008752D1
DE602006008752D1 DE602006008752T DE602006008752T DE602006008752D1 DE 602006008752 D1 DE602006008752 D1 DE 602006008752D1 DE 602006008752 T DE602006008752 T DE 602006008752T DE 602006008752 T DE602006008752 T DE 602006008752T DE 602006008752 D1 DE602006008752 D1 DE 602006008752D1
Authority
DE
Germany
Prior art keywords
expression
promoters
vectors
enhancer
recombinant proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006008752T
Other languages
English (en)
Inventor
Steven Geraint Williams
Jonathan Gawn
Alistair Simpson Irvine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0504587.7A external-priority patent/GB0504587D0/en
Application filed by Millipore Corp filed Critical Millipore Corp
Publication of DE602006008752D1 publication Critical patent/DE602006008752D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Image Generation (AREA)
  • Luminescent Compositions (AREA)
DE602006008752T 2005-03-05 2006-03-03 Neue regulatorische elemente enthaltende vektoren Active DE602006008752D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0504587.7A GB0504587D0 (en) 2005-03-05 2005-03-05 Vectors comprising guinea pig CMV regulatory elements
US66155305P 2005-03-14 2005-03-14
PCT/GB2006/000802 WO2006095156A1 (en) 2005-03-05 2006-03-03 Vectors comprising novel regulatory elements

Publications (1)

Publication Number Publication Date
DE602006008752D1 true DE602006008752D1 (de) 2009-10-08

Family

ID=36499814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008752T Active DE602006008752D1 (de) 2005-03-05 2006-03-03 Neue regulatorische elemente enthaltende vektoren

Country Status (6)

Country Link
EP (1) EP1856267B1 (de)
JP (2) JP4642865B2 (de)
AT (1) ATE440956T1 (de)
DE (1) DE602006008752D1 (de)
ES (1) ES2330784T3 (de)
WO (1) WO2006095156A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101038126B1 (ko) 2010-11-30 2011-05-31 주식회사 엘지생명과학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) * 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
GB8717430D0 (en) * 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
JP2005500019A (ja) * 2001-04-05 2005-01-06 エムエル ラボラトリーズ ピーエルシー 改良された遺伝子発現
KR20040032105A (ko) * 2001-06-04 2004-04-14 엠엘 래보러토리즈 피엘씨 재조합 단백질의 조성물 및 재조합 단백질의 고수준대규모 생산방법

Also Published As

Publication number Publication date
EP1856267B1 (de) 2009-08-26
JP4642865B2 (ja) 2011-03-02
ES2330784T3 (es) 2009-12-15
WO2006095156B1 (en) 2006-11-02
JP2011078415A (ja) 2011-04-21
ATE440956T1 (de) 2009-09-15
WO2006095156A1 (en) 2006-09-14
EP1856267A1 (de) 2007-11-21
JP2008529518A (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
DK1809750T3 (da) Selektion af værtsceller, der udtrykker protein ved høje niveauer
WO2005069762A3 (en) Bacillus licheniformis chromosome
ATE386811T1 (de) Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
WO2006012221A3 (en) Target cell-specific short interfering rna and methods of use thereof
TW200732472A (en) Method for the recombinant expression of a polypeptide
ATE371035T1 (de) Neue neomycin-phosphotransferase-gene und verfahren zur selektion von hochproduzierenden rekombinanten zellen
DE50311850D1 (de) Konstrukte und verfahren zur regulation der genexpression
DK1412505T3 (da) DNA-sekvenser til regulering af transkription
ATE494381T1 (de) Verbesserte expressionselemente
EP1841871A4 (de) Neuer l-lysin-induzierbarer promotor
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
DE60328673D1 (de) Optimierung von transgenexpression in säugetierzellen
WO2007015691A3 (en) Methods and compositions for increasing longevity and protein yield from a cell culture
ATE480629T1 (de) Auf cis einwirkende regulierende elemente aus tripsacum-dactyloiden
MX2010009071A (es) Peptidos aislados que tienen actividad inhibitoria de fosfolipasa.
ATE440956T1 (de) Neue regulatorische elemente enthaltende vektoren
WO2005034876A3 (en) Use of cell lines to produce active therapeutic proteins
ATE442445T1 (de) Rhamnose-induzierbares expressionssystem
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
ATE508189T1 (de) Zur beschleunigung der genexpressionbei einer mässig niedrigen temperatur fähige sequenz
EP1816203A4 (de) Für coronavirus-ähnliche partikel codierender expressionsvektor
DE50214936D1 (de) Verwendung des adenoviralen e2-late-promotors
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
ATE474928T1 (de) Verfahren zum herstellen von proteinen in einer hefe der gattung arxula und dafür geeignete promotoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1856267

Country of ref document: EP

Representative=s name: GRUND INTELLECTUAL PROPERTY GROUP, DE